Cristal Therapeutics to present data at the American Society of Clinical Oncology (ASCO) 2019 Annual Meeting on lead clinical candidate CPC634 in patients with solid tumors

Three poster presentations will be given by the company and its collaborators Florence Atrafi, MD, a clinical investigator on the phase 1 NAPOLY study, has received a prestigious ASCO Merit Award in recognition of her abstract that highlights important research findings Maastricht, The Netherlands, 17 May 2019 – Cristal Therapeutics, a clinical-stage pharmaceutical company developing […]

Knowledge for Growth

May 9 Knowledge for Growth Ghent, Belgium

China-BIO

May 8-9 China-BIO Shanghai, China

ESMO advanced ovarian cancer

February 22 ESMO advanced ovarian cancer Valencia, Spain